Some of the prominent players in the global high-throughput screening market research analysis such include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland), Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada).
The high-throughput screening (HTS) market is expected to grow at a lucrative CAGR of 7.8% from 2016 to 2021, high-throughput screening (HTS) market to reach USD 18.83 billion by 2021 from USD 12.23 billion in 2016.
To know about the assumptions considered for the study: get sample copy@ www.reportsnreports.com/contacts/r…aspx?name=274672
North America is the largest market for high-throughput screening, followed by Europe and Asia-Pacific. However, Asia-Pacific and Latin America possess lucrative growth potential for the high-throughput screening market during the forecast period.
This is mainly attributed to the increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding. Direct order For Complete Report Copy of High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021 at www.reportsnreports.com/purchase.aspx?name=274672
Market growth can be attributed to the growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising government funding.
Emerging markets and growing research activities in toxicology and stem cells provide significant growth opportunities for the market. On the other hand, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period.
High-throughput screening (HTS) market more focused Target Audience are:
- HTS Instrument & Reagent Manufacturers
- Pharmaceutical and Biotechnological Companies
- High-content Screening Database, Service, and Software Providers
- Business Research and Consulting Firms
- Academic Institutes and Government Organizations
- Clinical Research Organizations (CROs) & Clinical Manufacturing Organizations (CMOs)
- Healthcare Institutions (Hospitals, Medical Schools, and Outpatient Clinics)
- Government Bodies
- Venture Capitalists
“High-throughput screening (HTS) Market” spread across 256 pages, profiling 10 companies and supported with 237 tables and 39 figures is inquiry for full report @ www.reportsnreports.com/contacts/i….aspx?name=274672
The major players in the high-throughput screening market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland), Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A.
(Italy) and Aurora Biomed (Canada).
Key Point from Table of Content
High-Throughput Screening Market, By Product & Service
Consumables & Reagents
Software & Services
High-Throughput Screening Market, By Technology
2d Cell Culture
3D Cell Culture
Inert Matrix/Solid Scaffolds
Ultra-Low Binding Plates
Other Scaffold-Free Technologies
Perfusion Cell Culture
Inquire For This High-throughput screening (HTS) Market@ www.reportsnreports.com/contacts/d….aspx?name=274672